Exhaustive Study Guide: Cardiac Hemodynamics, Pharmacology, and Cardiovascular Medications

Core Concepts of Cardiac Hemodynamics and Clinical Pharmacology

Definition of Preload: * Preload is defined as the volume of blood entering the ventricles. * It represents the initial stretching of the cardiac myocytes (muscle cells) prior to the moment of contraction.
Definition of Afterload: * Afterload is characterized as the resistance that the left ventricle is required to overcome in order to circulate blood throughout the systemic circulation of the body.

Hemodynamic Determinants of Blood Pressure

The Blood Pressure Equation: * $\text{Blood Pressure (BP)} = \text{Cardiac Output (CO)} \times \text{Peripheral Resistance (PR)}$
Factors Influencing Cardiac Output (CO): * Heart Rate (HR): This is primarily controlled by the Sympathetic Nervous System (SNS). * Stroke Volume: This is determined by two main factors: myocardial contractility and preload. * Contractility: This is directly influenced by the Sympathetic Nervous System (SNS). * Preload Factors: Determined by Venous Arteriolar Venous Constriction and the overall Circulating Fluid Volume. * Renal Influence: Renal sodium handling dictates the circulating fluid volume; this process is regulated by the Renin-Angiotensin-Aldosterone System (RAAS).
Factors Influencing Peripheral Resistance (PR): * Vasoconstriction: This is controlled by the Vascular Smooth Muscle and the Renal System. * Vascular Remodeling: long-term structural changes in the blood vessel architecture.

Overview of Common Cardiovascular Medications

Primary Classes of Cardiovascular Drugs: * Anti-hypertension agents. * Antiarrhythmics. * Anticoagulants and platelet inhibitors. * Blood cholesterol-lowering agents (also known as antihyperlipidemics). * Oral Hypoglycemic Drugs. * Stool softeners.

Antihypertensive Drugs: Classification and Mechanisms

Primary Classes and Representative Examples: * Diuretics ("Water Pills"): Hydrochlorothiazide. * Beta Blockers: Propranolol, Metoprolol, Atenolol. * Vasodilators (Direct): Hydralazine. * Calcium Channel Blockers (CCBs): Amlodipine, Nifedipine, Verapamil, Diltiazem. * ACE Inhibitors (Angiotensin Converting Enzyme Inhibitors): Enalapril, Ramipril, Lisinopril. * ARBs (Angiotensin II Receptor Antagonists): Candesartan, Irbestartan, Valsartan. * Renin Inhibitors: Aliskiren. * Aldosterone Receptor Antagonists: Eplerenone. * Alpha-1 Adrenergic Blocking Agents: Prazosin. * Central-Acting Alpha-2 Agonists: Clonidine. * Peripheral-Acting Adrenergic Antagonists: Guanethidine.

Anatomical Sites and Specific Actions

Central Nervous System (CNS): * Alpha-2 agonists act here to decrease sympathetic impulses traveling from the CNS to the heart and arterioles, which results in vasodilation.
Arterioles: * Alpha-1 blockers: These inhibit sympathetic activation specifically in the arterioles to cause vasodilation. * Direct vasodilators: These act directly on the smooth muscle of the arterioles. * Calcium channel blockers: These block calcium ion channels located in the arterial smooth muscle to prevent contraction.
Heart: * Beta blockers: These act to decrease the heart rate and myocardial contractility, which subsequently reduces overall cardiac output.
Kidney & Fluid Regulation: * Diuretics: These increase the output of urine and decrease the total fluid volume in the body. * ACE Inhibitors: These function by blocking the formation of Angiotensin II and the subsequent secretion of aldosterone. * ARBs: These prevent Angiotensin II from reaching its specific receptors to block its effects.

Diuretics: Detailed Renal Pharmacology

Filtration, Reabsorption, and Secretion in the Nephron: * Renal Corpuscle: Responsible for generating the glomerular filtrate, which consists of water, ions, and small molecules. * Proximal Convoluted Tubule (PCT): * Reabsorbs: Sodium ( $Na^+$ ), chloride ( $Cl^-$ ), potassium ( $K^+$ ), water ( $H_2O$ ), glucose, amino acids, bicarbonate ( $HCO_3^-$ ), calcium ( $Ca^{2+}$ ), and phosphate. * Secretes: Ammonium ( $NH_4^+$ ) and creatinine. * Drug Action: This site is targeted by Carbonic Anhydrase Inhibitors (e.g., Acetazolamide) and Osmotic Diuretics (e.g., Mannitol). * Loop of Henle: * Thin Descending Limb: Primarily reabsorbs water ( $H_2O$ ). * Thin Ascending Limb: Reabsorbs sodium ( $Na^+$ ) and chloride ( $Cl^-$ ). * Thick Ascending Limb: Reabsorbs ammonium ( $NH_4^+$ ), sodium ( $Na^+$ ), and chloride ( $Cl^-$ ). * Drug Action: Loop Diuretics (e.g., Furosemide) act here by inhibiting the $Na^+/K^+/2Cl^-$ cotransporter. * Distal Convoluted Tubule (DCT): * Reabsorbs: Sodium ( $Na^+$ ) and chloride ( $Cl^-$ ). * Drug Action: Thiazides act here by inhibiting the sodium-chloride transporter. * Collecting Duct: * Reabsorbs: Sodium ( $Na^+$ ), chloride ( $Cl^-$ ), and water ( $H_2O$ ). * Secretes: Ammonium ( $NH_4^+$ ), hydrogen ions ( $H^+$ ), and potassium ( $K^+$ ). * Drug Action: Aldosterone antagonists (e.g., Spironolactone) and potassium-sparing agents (e.g., Triamterene) act here by blocking sodium channels or aldosterone receptors.

Classification and Characteristics of Diuretics

Loop Diuretics (e.g., Furosemide, Bumetanide, Torsemide): * Mechanism: These drugs inhibit sodium transport in the thick segments of the ascending limbs of the Loop of Henle. * Efficacy: Recognized as the most efficacious diuretics available.
Thiazides (e.g., Hydrochlorothiazide): * Mechanism: These work by inhibiting sodium transport in the final part of the ascending limb and the first part of the distal tubule.
Carbonic Anhydrase Inhibitors (e.g., Acetazolamide): * Mechanism: These inhibit the reabsorption of bicarbonate in the proximal tubule. They are considered to have only weak diuretic properties.
Osmotic Diuretics (e.g., Mannitol): * Mechanism: These agents reduce the osmotic reabsorption of water by reducing the osmotic gradient within the nephron.
Potassium-Sparing Diuretics: * Spironolactone: This drug inhibits the action of aldosterone at the distal tubule and the cortical collecting duct. * Triamterene and Amiloride: These drugs inhibit $Na^+$ reabsorption and $K^+$ secretion.

Side Effects and Complications of Diuretics

Shared Side Effects: Hypotension, Hyperuricemia, and Metabolic Alkalosis (associated specifically with Loops and Thiazides).
Loop and Thiazide Specific Side Effects: * Hypokalemia ( $\text{Hypo-K}^+$ ). * Hyponatremia ( $\text{Hypo-Na}^+$ ). * Hypomagnesemia ( $\text{Hypo-Mg}^{2+}$ ). * Hypovolemia. * Azotemia (noted specifically for Thiazides). * Ototoxicity (noted specifically for Loop diuretics). * Hyperglycemia (noted specifically for Thiazides).
K-Sparing Specific Side Effects: * Hyperkalemia ( $\text{Hyper-K}^+$ ). * Metabolic Acidosis. * Gynecomastia (associated specifically with Spironolactone).
General Complications of Diuretic Use: * Dehydration and electrolyte imbalance. * Arrhythmias and potential sudden cardiac death. * Increased frequency of muscle cramps. * Renal disease. * Impotence.

Beta-Adrenergic Blockers: Receptors and Classifications

Adrenergic Receptor Functions: * $\alpha_1$ : Responsible for vasoconstriction, increased peripheral resistance, increased blood pressure, and mydriasis. * $\alpha_2$ : Responsible for the inhibition of norepinephrine, acetylcholine, and insulin release. * $\beta_1$ (primarily in the Heart): Causes tachycardia, increased lipolysis, increased myocardial contractility, and increased renin release. * $\beta_2$ (primarily in Lungs and Vessels): Causes vasodilation, bronchodilation, increased glycogenolysis, and relaxation of uterine smooth muscle.
Generations and Classification of Beta Blockers: * 1st Generation (Non-selective, No Vasodilation): Propranolol, Timolol, Sotalol. * 2nd Generation ( $\beta_1$ -selective, No Vasodilation): Atenolol, Bisoprolol, Metoprolol. * 3rd Generation: * $\beta_1$ -selective with Vasodilation: Nebivolol, Acebutolol. * Non-selective with Vasodilation: Carvedilol, Bucindolol, Labetalol (the latter acts via $\alpha_1$ blocking activity).
Intrinsic Sympathomimetic Activity (ISA): * Some beta blockers act as partial agonists; examples include Pindolol and Acebutolol.
Side Effects of Beta Blockers: * Bradycardia. * Lethargy and Depression. * Gastrointestinal (GI) Disturbance. * Congestive Heart Failure (CHF). * Decreased Blood Pressure.

Calcium Channel Blockers (CCBs)

Chemical Classification and Representative Examples: * Phenylalkylamines: Verapamil (Generations: Calan, Isoptin SR). * Benzothiazepines: Diltiazem (Generations: Cardizem CD). * 1,4-Dihydropyridines: * 1st Generation: Nifedipine. * 2nd Generation: Nicardipine, Isradipine, Felodipine. * 3rd Generation: Amlodipine (Norvasc).
Comparison of Adverse Effects (Severity Scale): * Headaches: Dihydropyridines (+++); Verapamil (++). * Peripheral Edema: Dihydropyridines (+++); Diltiazem (+). * Constipation: Verapamil (++); Others (0). * AV Block: Verapamil (+++); Diltiazem (++). * Caution Required with Beta Blockers: Verapamil (+++); Diltiazem (++).

RAAS Inhibitors: ACE-Is and ARBs

ACE Inhibitors (Nomenclature ends in -PRIL): * Mechanism: These block the enzyme that converts Angiotensin I into Angiotensin II. They also prevent the breakdown of Bradykinin, which leads to increased levels of Nitric Oxide (NO) and Prostacyclins, both of which are vasodilators. * Captopril Side Effects (Mnemonic: CAPTOPRIL): * C: Cough (associated with C1 esterase deficiency). * A: Angioedema and Agranulocytosis. * P: Proteinuria and Potassium excess (hyperkalemia). * T: Taste change. * O: Orthostatic hypotension. * P: Pregnancy contraindication (due to the risk of fetal renal damage). * R: Renal artery stenosis contraindication. * I: Increase in renin levels. * L: Leukopenia and Liver toxicity.
ARBs (Nomenclature ends in -SARTAN): * Mechanism: These agents block Angiotensin II directly at the $AT_1$ receptor. * Effects: Inhibition of vasoconstriction, sympathetic activation, cell proliferation, and aldosterone release.
Heart Failure Combination Therapy: * Entresto: A specific combination drug consisting of Sacubitril (a neprilysin inhibitor) and Valsartan (an ARB), used for treating chronic heart failure.

Other Adrenergic and Vasodilator Drugs

Alpha Blockers: * Classifications: * Non-selective: Includes Reversible (Phentolamine) and Irreversible (Phenoxybenzamine) types. * Selective $\alpha_1$ Blockers: Prazosin, Terazosin, Doxazosin, Tamsulosin. * Side Effects: Postural hypotension, reflex tachycardia, headache (due to cranial vasodilation), nasal congestion, and decreased ejaculation.
Nitroglycerin: * Uses: Utilized for the treatment and prevention of angina pectoris and to lower blood pressure. * Available Forms: Extended-release tablets, translingual spray, and transdermal patches. * Caution: Patients should not stack nitroglycerin with other high blood pressure medications because of the risk of additive effects.

Medications Affecting Exercise Response

Beta Blockers: These medications blunt the Heart Rate and Blood Pressure response during exercise.
Calcium Channel Blockers: These decrease both resting and exercise blood pressure; they carry a risk of reflex tachycardia and post-exercise hypotension.
Digitalis: This medication may cause dysrhythmias and tachycardia during physical activity.
Bronchodilators (Non-selective $\beta$ agonists): These may increase heart rate and blood pressure, creating a risk for dysrhythmias.
Diuretics: These can cause dysrhythmias, fluid depletion, or severe dehydration during exercise.
Vasodilators: These increase the risk of experiencing post-exercise hypotension.

Anticoagulants and Platelet Inhibitors

Anticoagulant Examples: * Dalteparin (Fragmin). * Enoxaparin (Lovenox). * Fondaparinux (Arixtra). * Heparin. * Warfarin (Coumadin).
Antiplatelet Mechanisms and Examples: * COX Inhibitors: Aspirin. * ADP Antagonists (Thienopyridines): Clopidogrel (Plavix), Prasugrel, Ticlopidine. * Phosphodiesterase Inhibitors: Dipyramidamole (Persantine), Cilostazol. * GP IIb/IIIa Inhibitors: Abciximab, Eptifibatide, Tirofiban.

Antiarrhythmics (Vaughn-Williams Classification)

Class IA: Moderate sodium ( $Na$ ) block. Examples: Quinidine, Procainamide. These drugs prolong the QRS and QT intervals.
Class IB: Mild sodium ( $Na$ ) block. Examples: Lidocaine, Mexiletine. These decrease ventricular automaticity.
Class IC: Marked sodium ( $Na$ ) block. Examples: Flecainide, Propafenone. These prolong the QRS interval.
Class II: Beta-blockers. Examples: Propranolol, Esmolol. These decrease heart rate and AV conduction.
Class III: Potassium ( $K$ ) channel block. Examples: Amiodarone, Sotalol. These drugs prolong repolarization and the QT interval.
Class IV: Calcium ( $Ca$ ) channel block in nodes. Examples: Verapamil, Diltiazem. These increase the PR interval.

Antihyperlipidemics: Mechanisms and Side Effects

Mechanisms of Action: * Statins (HMG CoA Reductase Inhibitors): Atorvastatin, Simvastatin. These work by inhibiting cholesterol synthesis and increasing the expression of hepatocyte LDL receptors. * Fibric Acid Derivatives (Fibrates): Fenofibrate, Gemfibrozil. These act as PPAR-alpha agonists; they upregulate lipoprotein lipase to catabolize VLDL and triglycerides. * Bile Acid Sequestrants: Cholestyramine, Colesevelam. These interrupt the enterohepatic circulation of bile acids, leading to an increase in LDL receptor expression. * Ezetimibe: This drug inhibits the intestinal absorption of cholesterol. * PCSK9 Inhibitors: Alirocumab, Evolocumab. These prevent the recycling of LDL receptors to optimize LDL removal from the blood. * Novel Agents: * Mipomersen: An antisense oligonucleotide (ASO) directed against the Apo B coding region. * Lomitapide: An MTP inhibitor that prevents the formation of chylomicrons and VLDL. * Bempendoic Acid: An ATP citrate lyase inhibitor.
Side Effects and Contraindications: * Statins: Side effects include myopathy and increased liver enzymes. They have an absolute contraindication in patients with active liver disease. * Niacin: Can cause flushing, hyperglycemia, hyperuricemia (gout), and hepatotoxicity. * Fibrates: Side effects include dyspepsia, gallstones, and myopathy. They are contraindicated in patients with severe renal or hepatic disease.

Diabetes Mellitus Pharmacology

Chronic Symptoms of Insulin Deficit: * Decreased glucose uptake results in Hyperglycemia and Glycosuria. * Osmotic diuresis occurs, leading to Polyuria, Dehydration, and Polydipsia (excessive thirst). * Increased lipolysis and ketogenesis lead to Lipidemia, Ketoacidosis, and Ketonuria. This manifests clinically as Acetone breath and Hyperpnea.
Oral Hypoglycemic Classes: * Sulfonylureas (e.g., Gliclazide, Glipizide): These chronically increase insulin secretion. * Biguanides (Metformin): These decrease hepatic glucose production and are considered first-line therapy. * Thiazolidinediones (Pioglitazone): These act to decrease insulin resistance. * $\alpha$ -glucosidase Inhibitors (Acarbose): These decrease postprandial carbohydrate absorption in the gut. * GLP-1 Analogues (Liraglutide): These stimulate insulin secretion and slow the process of gastric emptying. * DPP4 Inhibitors (Sitagliptin): These work to suppress glucose production.
Insulin Profiles: * Rapid-Acting (Humalog, Novorapid): Onset is within $10-15\,min$ ; Peak occurs at $60-90\,min$ . These are typically used pre-meal. * Short-Acting (Humulin R): Onset is within $30\,min$ ; Peak occurs at $2-3\,h$ . These are used pre-meal. * Intermediate-Acting (Humulin N/NPH): Onset is within $1-3\,h$ ; Peak occurs at $5-8\,h$ . This is used as basal insulin. * Long-Acting (Lantus, Levemir): Onset is within $90\,min$ ; there is no peak (Flat profile). The duration spans up to $24\,h$ . * Premixed (Humalog Mix 75/25): The profile varies based on the specific composition percentage (e.g., 30% rapid mixed with 70% intermediate).
Hypoglycemia Signs (Low Blood Sugar): * Common signs include trembling, sweating, dizziness, paleness, blurred vision, extreme tiredness, and mood changes.